BioCorRx Pharmaceuticals

BioCorRx Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing long-acting treatment solutions for substance use disorders, particularly opioid and alcohol addiction. The company's lead product candidate, BICX104, is a biodegradable naltrexone implant designed to provide sustained release of the medication over several months, addressing the critical issue of patient non-compliance in addiction recovery. BioCorRx has received significant support and grant funding from the National Institute on Drug Abuse (NIDA) to advance its clinical programs. In addition to its pharmaceutical pipeline, the company operates the Beat Addiction Recovery Program, which integrates medication-assisted treatment with proprietary behavioral therapy. By focusing on improved delivery systems for proven molecules, BioCorRx aims to reduce relapse rates and improve long-term outcomes for individuals struggling with addiction.